Skip to main content
. 2023 Jun 23;19:54. doi: 10.1186/s13223-023-00805-3
Parameter, n (%) AEs of interest Other AEs SAEs
PID SID PID SID PID SID
Patients, n (%)
(N = 61)
AEs, n Patients, n (%)
(N = 64)
AEs, n Patients, n (%)
(N = 61)
AEs, n Patients, n (%)
(N = 64)
AEs, n Patients, n (%)
(N = 61)
AEs, n Patients, n (%)
(N = 64)
AEs, n
Any AE 11 (18.0) 16 5 (7.8) 7 7 (11.5) 13 12 (18.8) 13 1 (1.6) 1 4 (6.3) 4
Severity of AE
 Mild 8 (13.1) 11 3 (4.7) 3 5 (8.2) 7 5 (7.8) 6 0 0 0 0
 Moderate 3 (4.9) 4 2 (3.1) 4 2 (3.3) 6 4 (6.3) 4 0 0 1 (1.6) 1
 Severe 1 (1.6) 1 0 0 0 0 3 (4.7) 3 1 (1.6) 1 3 (4.7) 3
AEs considered related to Ig20Gly
 Related 5 (8.2) 6 2 (3.1) 2 2 (3.3) 2 1 (1.6) 2 0 0 0 0
 Possibly related 3 (4.9) 3 2 (3.1) 4 2 (3.3) 2 2 (3.1) 2 1 (1.6) 1 0 0
 Probably related 1 (1.6) 1 1 (1.6) 1 1 (1.6) 1 1 (1.6) 1 0 0 0 0